4/A: GeneDx Holdings Director Amends Filing to Include Indirect Holdings
SEC Form 4 Amendment
A GeneDx Holdings director, Joshua Ruch, amended a previous filing to include indirect holdings of Class A Common Stock through various investment entities.
Summary
- Joshua Ruch, a director at GeneDx Holdings Corp., filed an amendment to a previous Form 4 to include indirect holdings of Class A Common Stock.
- The amended filing includes holdings through Kariba LLC, Rugu2 LLC, and VAAL Investment Partners Q9 LP.
- Mr. Ruch is a managing member of the managing member of the general partner of Vaal Investment Partners Q9 LP, a managing member of RUGU2 LLC, and a managing member of Kariba LLC.
- Mr. Ruch disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.
- The original filing was made on October 17, 2024, and the amendment was filed on November 21, 2024.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing, and the amendment is a correction of an omission, not indicative of any positive or negative sentiment. The sentiment is neutral to slightly positive as it shows transparency.
Industry Context
This filing is a routine disclosure of beneficial ownership by a company director, which is a standard practice in corporate governance and regulatory compliance.
Comparison to Industry Standards
- Form 4 filings are a standard requirement for corporate insiders in the US, and this amendment is consistent with the regulatory expectations for accurate and timely disclosure of beneficial ownership.
- Similar filings are made by directors and officers of all publicly traded companies in the US, such as those in the biotechnology sector like Illumina or Exact Sciences, when they have changes in their holdings.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the holdings of a company director.
- The amendment ensures accurate reporting of beneficial ownership, which is important for investor confidence.
Key Dates
| Date | Description |
|---|---|
| 10/15/2024 | Date of the earliest transaction reported in the filing. |
| 10/17/2024 | Date of the original Form 4 filing that was amended. |
| 11/21/2024 | Date of the amended Form 4 filing. |
Keywords
GeneDx Holdings, Form 4, Beneficial Ownership, Indirect Holdings, Director, Joshua Ruch, Class A Common Stock, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.